INVO Fertility, Inc. (IVF)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $2.86M
Last updated: Nov 17, 2026 at 4:10 PM ET
INVO Fertility, Inc. (IVF) Stock Chart
INVO Fertility (IVF) has a latest price of $2.18 on Nov 17, 2026, 96.9% below its 52-week high of $69.92. Its price fell 97.2% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 73.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $2,364,258.96 in Apr 2018 and its lowest $1.91 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IVF with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IVF.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 51.8%, and over 6 months it fell 61.9%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 93.6%.
| Period | Change |
|---|---|
| 1 month | -9.3% |
| 3 months | -51.8% |
| 6 months | -61.9% |
| 12 months | -97.2% |
| 12 months, with dividends | -97.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -100.0% | -93.6% |
| 5 years | -100.0% | -91.4% |
| 10 years | -100.0% | -73.8% |
Price by Year
Its best calendar year was 2018, when the price rose 171.0%, and its weakest was 2025, when it fell 99.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.91 | -87.3% |
| 2025 | $15.05 | -99.7% |
| 2024 | $4,667.93 | -40.0% |
| 2023 | $7,779.89 | -84.1% |
| 2022 | $48,846.18 | -87.3% |
| 2021 | $383,807.89 | +10.6% |
| 2020 | $346,925.45 | -56.6% |
| 2019 | $798,676.23 | -48.5% |
| 2018 | $1,551,544.94 | +171.0% |
| 2017 | $572,593.97 | -55.7% |
Trading Range
The price is 25.1% below its 50-day average of $2.91 and 71.0% below its 200-day average of $7.52.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.18 | |
| 52-week high | $69.92 | -96.9% |
| 52-week low | $1.59 | +37.1% |
| 50-day average | $2.91 | -25.1% |
| 200-day average | $7.52 | -71.0% |
Price Risk
Over 3 years, its largest fall from a peak was 100.0%.
| Measure | Value |
|---|---|
| 1-year beta | -0.25 |
| Largest fall, 1 year | -97.5% |
| Largest fall, 3 years | -100.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IVF
What is IVF's 1-year price change?
INVO Fertility's price fell 97.2% over the past 12 months. With dividends included, the 12-month total return was -97.2%.
What is IVF's 5-year price change?
INVO Fertility's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 91.4%. These figures leave out dividends.
What is IVF's 52-week high and low?
INVO Fertility's 52-week high is $69.92 and its 52-week low is $1.59. Its latest price of $2.18 on Nov 17, 2026 is 96.9% below the high.
What is IVF's beta?
INVO Fertility's 1-year beta against the S&P 500 is -0.25, so its price has tended to move against the market over the past year. Its largest fall from a peak over the past year was 97.5%.
Is the IVF chart free?
Yes. Advanced Charting for IVF is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IVF pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors